Faster results with the new VACUETTE® CAT Serum Fast Separator Tube


VACUETTE® CAT Serum Fast Separator enables complete clotting of the whole blood sample in just 5 minutes and thus offers a decisive time advantage compared to conventional serum tubes.

Kremsmünster, May 2023 – Time is of the essence when it comes to accurate and fast results for treating patients. Fast clotting following blood collection allows crucial minutes to be saved.

The best of both worlds

Heparinized plasma is often used as an emergency tube as there is no need to wait for clotting. Serum is sometimes indispensable in emergency departments and this is precisely where VACUETTE® CAT Serum Fast Separator Tubes can save enormous amounts of time. The VACUETTE® CAT Serum Fast Separator Tube combines the speed of a plasma tube with the advantages of serum quality in terms of erythrocytes remaining after centrifugation. It allows clotting of the whole blood sample to be continued in just 5 minutes, this considerably shortening the preanalytical process.

Reduced turnaround time (TAT)

The quality of a laboratory is often measured by how many samples can be processed within a given time. The indicator is the turnaround time (TAT), i.e. the time between blood collection and receipt of the results. That time is significantly reduced by using the VACUETTE® CAT Serum Fast Separator Tube.

Thanks to the short clotting time of just 5 minutes, followed by centrifugation for 5 minutes, the analysis of key clinical chemical parameters can begin after just 10 minutes, allowing reliable results to be attained far quicker. This makes it easy to effectively reduce turnaround time (TAT) by 30 minutes per sample and targeted treatment can be initiated more rapidly.

Optimized clotting process

The interior of the shatter-proof VACUETTE® CAT Serum Fast Separator Tube is coated with a mixture of blood clot activator and thrombin. The tube contains a gel that forms a stable barrier between the serum and the solid components. Thrombin in the additive speeds up the clotting process in the blood sample.

Company: Greiner Bio-One GmbH

Greiner Bio-One specializes in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, BioScience and Sterilization. As an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of custom-made design developments and production processes for the life sciences and medical sectors.
In 2021, Greiner Bio-One International GmbH generated a turnover of 695 million euros and had 2,540 employees, 28 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner AG, which is based in Kremsmünster (Austria).

Send Enquiry for this story

By submitting this form you are giving a consent to to store your submitted information.
See our Privacy Policy to learn more about how we use data.